Effects of pentasaccharide (Fondaparinux) and direct thrombin inhibitors on coagulation testing

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 10, 2004, Pages 1142-1145

  Gosselin, Robert C ^a   King, Jeffrey H ^a   Janatpur, Kim A ^a   Dager, William H ^a   Larkin, Edward C ^a   Owings, John T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ARGATROBAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; CHROMOGENIC SUBSTRATE; D DIMER; FIBRINOGEN; FONDAPARINUX; HIRULOG; LEPIRUDIN; LUPUS ANTICOAGULANT; PENTASACCHARIDE; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; THROMBIN INHIBITOR; VON WILLEBRAND FACTOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TEST; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; IN VITRO STUDY; LATEX AGGLUTINATION TEST; PROTEIN BLOOD LEVEL; THROMBOCYTE AGGREGATION;

ANTITHROMBINS; BLOOD COAGULATION TESTS; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; PIPECOLIC ACIDS; POLYSACCHARIDES; RECOMBINANT PROTEINS;

EID: 4744355141     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dager WE, White RH. Treatment of heparin-induced thrombocytopenia. Ann Pharmacother. 2002;36:489-503.
2. Hirsh J, Weitz JI. New antithrombic agents. Lancet. 1999;353:1431-1436.
3. Sheth SB, DiCicco RA, Hursting MJ, Montague T, Jorkasky DK. Interpreting the international normalized ratio (INR) in individuals receiving argatroban and warfarin [published correction appears in Thromb Haemost. 2001;86:727]. Thromb Haemost. 2001;85:435-440.
4. Hursting MJ, Zehnder JL, Joffrion JL, Becker JC, Knappenberger GD, Schwarz RP Jr. The international normalized ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used. Clin Chem. 1999;45:409-412.
5. Fenyvesi T, Jorg I, Harenberg J. Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method. Pathophysiol Haemost Thromb. 2002;32:174-179.
6. Gosselin RC, Dager WE, King JH, et al. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. Am J Clin Pathol. 2004;121:593-599.
7. Walenga JM, Fasanella AR, Iqbal O, et al. Coagulation laboratory testing in patients treated with argatroban. Semin Thromb Hemost. 1999;25(suppl 1):61-66.
8. Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J. Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests. Clin Appl Thromb Hemost. 2002;8:325-336.
9. Boneu B, Necciari J, Cariou R, et al. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man. Thromb Haemost. 1995;74:1468-1473.
10. Trask AS, Gosselin RC, Diaz JA, Dager WE. Initiating and monitoring warfarin using clotting factors II, VII and X. Ann Pharmacother. 2004;38:251-256. Epub December 30, 2003.